| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $38K | +0.0% |
| R&D Expense | $4.1M | -73.4% |
| SG&A Expense | $6.4M | +18.2% |
| Operating Income | -$10.6M | +49.5% |
| Pre-tax Income | -$10.6M | +48.8% |
| Net Income | -$10.6M | +48.8% |
| EPS (Basic) | -$1.60 | +82.6% |
| EPS (Diluted) | -$1.60 | +82.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $865K | -75.2% |
| Current Assets | $1.5M | -61.9% |
| Total Assets | $1.5M | -70.4% |
| Total Liabilities | $1.7M | -6.3% |
| Stockholders' Equity | -$212K | -106.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.6M | -17.9% |
| Investing Cash Flow | -$936K | +0.0% |
| Financing Cash Flow | $6.0M | +2006.1% |